Home > News > The Evolution in Glaucoma Surgery – Latest Advances in Filtration Surgery
Glaucoma
Read Time: < 1 min

The Evolution in Glaucoma Surgery – Latest Advances in Filtration Surgery

Published Online: January 23rd 2013 European Ophthalmic Review, 2012;6(5):269-274 DOI: http://doi.org/10.17925/EOR.2012.06.05.269
Authors: Katrina Mountfort
Quick Links:
Article
Article Information
Article:

Abstract

In recent years, an increased understanding of intraocular pressure (IOP) has facilitated advances in surgical techniques in the treatment of glaucoma. Although trabeculectomy has been the gold standard of glaucoma surgery for over four decades, new devices have recently

Abstract

In recent years, an increased understanding of intraocular pressure (IOP) has facilitated advances in surgical techniques in the treatment of glaucoma. Although trabeculectomy has been the gold standard of glaucoma surgery for over four decades, new devices have recently
been introduced, including the EX-PRESS™ glaucoma filtration device (GFD). An important requirement of any surgical or medical procedure to lower IOP is effectiveness over a 24-hour period, since IOP is at its highest at night. Recent data have demonstrated that the EX-PRESS™ GFD can achieve a similar reduction in IOP to that achieved by trabeculectomy, but with a significantly reduced rate of complications. Following the successful learning of a number of surgical techniques, most of which are currently mastered by the skilled trabeculectomy surgeon, implantation of the Ex-PRESS TM GFD is no more challenging than a traditional trabeculectomy and provides rapid post-operative recovery. Since cost considerations prohibit the use of the EX-PRESS™ GFD in all cases of glaucoma surgery, patient selection is important. It must be stressed, however, that use of the EX-PRESS™ GFD results in reduced indirect costs as a result of its better predictability, shorter operative time and reduced short-term post-operative complications.

Support: The publication of this article was funded by Alcon. The views and opinions expressed are those of the author and not necessarily those of Alcon.

To view the full article in PDF or eBook formats, please click on the icons above.

Article Information:

Further Resources

Share this Article
Related Content In Glaucoma
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72